The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Purpose Bitcoin ETF
BTCC:CA
Soma Gold Corp.
SOMA:CA
Silver47 Exploration
AGA:CC
Black Swan Graphene
SWAN:CC
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Resverlogix Announces TSX Review Update
Apr. 12, 2018 09:06AM PST
Genetics InvestingResverlogix (TSX:RVX) announced today it has received a 30-day extension to no later than May 14, 2018 for the TSX’s review of the Company’s compliance with all of the TSX listing requirements. As quoted in the press release: As previously reported, as a result of the Company’s reliance upon the financial hardship exemption in connection …
Resverlogix (TSX:RVX) announced today it has received a 30-day extension to no later than May 14, 2018 for the TSX’s review of the Company’s compliance with all of the TSX listing requirements.
As quoted in the press release:
As previously reported, as a result of the Company’s reliance upon the financial hardship exemption in connection with the Company’s previously-announced $87 million private placement with Shenzhen Hepalink Pharmaceutical Co. Ltd., the TSX commenced an automatic remedial delisting review, which is normal practice when a listed issuer relies on this exemption. The Company anticipates further improving its financial position by raising additional capital, including closing a previously-announced US$30 million senior secured loan.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.